RecruitingPhase 1NCT06085937

Feasibility and Safety of Ketamine for Suicidal Patients in the Emergency Department

Feasibility and Safety of Single Dose Ketamine for Acutely Suicidal Patients in the Emergency Department


Sponsor

Lindsay Maguire, MD

Enrollment

50 participants

Start Date

May 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

There is currently no readily available pharmacologic intervention for suicidal ideation, a true psychiatric emergency, in the Emergency Department (ED). Investigators aim to trial low-dose, intravenous ketamine, a drug with well-established use in treatment-resistant depression, for patients who present to the ED with suicidal ideation.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This study is exploring whether a low dose of ketamine — a medication already used for pain and anesthesia — can quickly reduce suicidal thoughts in people who come to the emergency department in a mental health crisis. Researchers want to see if this approach is safe and helpful while patients await psychiatric care. **You may be eligible if...** - You are between 18 and 65 years old - You are experiencing active suicidal thoughts and require inpatient psychiatric stabilization - You are fully alert (Glasgow Coma Score of 15) - You are being admitted to the University of Kansas Medical Center's psychiatric unit **You may NOT be eligible if...** - You have a history of psychosis or schizophrenia - You have had manic or hypomanic symptoms in the past 4 weeks - You have a history of ketamine misuse or addiction - You have had a liver transplant - You are pregnant or breastfeeding - Your blood pressure is dangerously high or low - You tested positive for drugs or alcohol - You have an acute medical condition requiring hospitalization Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGKetamine

Patients will receive 0.2mg/kg of IV ketamine


Locations(2)

University of Kansas Strawberry Hill Campus

Kansas City, Kansas, United States

University of Kansas Medical Center Emergency Department

Kansas City, Kansas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06085937


Related Trials